Cargando…
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
The surfaces of the abdomen and pelvis are an important anatomic site for the dissemination of gastrointestinal and gynecologic malignancy. This transcoelomic spread of cancer cells gives rise to peritoneal carcinomatosis which, without special treatments, is a fatal manifestation of these diseases....
Autores principales: | Van der Speeten, Kurt, Stuart, Oswald Anthony, Sugarbaker, Paul H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764866/ https://www.ncbi.nlm.nih.gov/pubmed/19275544 http://dx.doi.org/10.2174/157016309787581084 |
Ejemplares similares
-
Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients
por: Van der Speeten, K., et al.
Publicado: (2012) -
Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization
por: Lemoine, Lieselotte, et al.
Publicado: (2019) -
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
por: Lemoine, Lieselotte, et al.
Publicado: (2016) -
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
por: Yan, Tristan D, et al.
Publicado: (2006) -
Peritoneal Surface Malignancies Originating From Urachal Carcinoma: Case Reports and Review of the Literature
por: Van Breusegem, Paulien, et al.
Publicado: (2022)